-
Je něco špatně v tomto záznamu ?
Predictors of survival in patients with pulmonary hypertension and acute right heart failure
D. Ambroz, P. Jansa, J. Kuchar, J. Belohlavek, M. Aschermann, V. Dytrych, J. Lindner, I. Simkova, A. Linhart
Jazyk angličtina Země Slovensko
- MeSH
- analýza přežití * MeSH
- antihypertenziva terapeutické užití MeSH
- dysfunkce pravé srdeční komory MeSH
- hospitalizace MeSH
- interpretace statistických dat MeSH
- kombinovaná terapie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mortalita v nemocnicích MeSH
- plicní arteriální hypertenze diagnóza terapie MeSH
- plicní hypertenze * diagnóza terapie MeSH
- randomizované kontrolované studie jako téma MeSH
- retrospektivní studie MeSH
- senioři MeSH
- srdeční selhání etiologie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- senioři MeSH
OBJECTIVES: The aim of this study was to analyse survival of patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) hospitalized due to an acute right heart failure (ARHF) with emphasis on risk factors and effectiveness of treatment following current guidelines. METHODS: We retrospectively analysed 117 hospitalizations of 70 patients (59 PAH patients; 11 CTEPH patients, mean age 53.1 ± 16.77 years, 54 % females) between 2004 and 2013. RESULTS: 96 cases were hospitalized at cardiology wards (CW) while 21 at intensive care unit (ICU). The overall hospital mortality was 12.8 %, CW mortality was 4 %, and ICU mortality was 52.4 %. Higher risk of in-hospital mortality was associated with younger age, lower sodium levels, severe forms of PAH (heritable PAH, CTD-PAH) and need of PAH combination treatment. The one-year survival from the first ARHF hospitalization was 67.6 % (95 % CI 57.1–80 %), the two-year survival was 41.9 % (95 % CI 30.8–56.9 %). The presence of ascites was a predictor of long-term mortality. CONCLUSIONS: Mortality in patients with PH and ARHF remains very high. Identification of its risk factors could be used as basis of risk-adapted therapy (Tab. 5, Fig. 2, Ref. 14).
Department of Cardiology Tabor Hospital Inc Czech Republic
Slovak Medical University and The National Institute for Cardiovascular Diseases Bratislava Slovakia
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21024803
- 003
- CZ-PrNML
- 005
- 20240905221118.0
- 007
- cr|cn|
- 008
- 211012s2020 xo d fs 000 0|eng||
- 009
- AR
- 024 0_
- $a 10.4149/BLL_2020_035 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Ambrož, David $7 xx0072987 $u Clinical Department of Cardiology and Angiology, 1st Faculty of Medicine, 2nd Medical Department, Charles University, Prague, Czech Republic
- 245 10
- $a Predictors of survival in patients with pulmonary hypertension and acute right heart failure / $c D. Ambroz, P. Jansa, J. Kuchar, J. Belohlavek, M. Aschermann, V. Dytrych, J. Lindner, I. Simkova, A. Linhart
- 504 __
- $a Literatura
- 520 9_
- $a OBJECTIVES: The aim of this study was to analyse survival of patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) hospitalized due to an acute right heart failure (ARHF) with emphasis on risk factors and effectiveness of treatment following current guidelines. METHODS: We retrospectively analysed 117 hospitalizations of 70 patients (59 PAH patients; 11 CTEPH patients, mean age 53.1 ± 16.77 years, 54 % females) between 2004 and 2013. RESULTS: 96 cases were hospitalized at cardiology wards (CW) while 21 at intensive care unit (ICU). The overall hospital mortality was 12.8 %, CW mortality was 4 %, and ICU mortality was 52.4 %. Higher risk of in-hospital mortality was associated with younger age, lower sodium levels, severe forms of PAH (heritable PAH, CTD-PAH) and need of PAH combination treatment. The one-year survival from the first ARHF hospitalization was 67.6 % (95 % CI 57.1–80 %), the two-year survival was 41.9 % (95 % CI 30.8–56.9 %). The presence of ascites was a predictor of long-term mortality. CONCLUSIONS: Mortality in patients with PH and ARHF remains very high. Identification of its risk factors could be used as basis of risk-adapted therapy (Tab. 5, Fig. 2, Ref. 14).
- 650 17
- $a plicní hypertenze $x diagnóza $x terapie $7 D006976 $2 czmesh
- 650 07
- $a plicní arteriální hypertenze $x diagnóza $x terapie $7 D000081029 $2 czmesh
- 650 07
- $a dysfunkce pravé srdeční komory $7 D018497 $2 czmesh
- 650 07
- $a srdeční selhání $x etiologie $7 D006333 $2 czmesh
- 650 07
- $a kombinovaná terapie $7 D003131 $2 czmesh
- 650 07
- $a hospitalizace $7 D006760 $2 czmesh
- 650 07
- $a mortalita v nemocnicích $7 D017052 $2 czmesh
- 650 07
- $a antihypertenziva $x terapeutické užití $7 D000959 $2 czmesh
- 650 07
- $a lidé $7 D006801 $2 czmesh
- 650 07
- $a lidé středního věku $7 D008875 $2 czmesh
- 650 07
- $a senioři $7 D000368 $2 czmesh
- 650 07
- $a retrospektivní studie $7 D012189 $2 czmesh
- 650 07
- $a interpretace statistických dat $7 D003627 $2 czmesh
- 650 17
- $a analýza přežití $7 D016019 $2 czmesh
- 650 07
- $a randomizované kontrolované studie jako téma $7 D016032 $2 czmesh
- 700 1_
- $a Jansa, Pavel, $d 1971- $7 jo2008427138 $u Clinical Department of Cardiology and Angiology, 1st Faculty of Medicine, 2nd Medical Department, Charles University, Prague, Czech Republic
- 700 1_
- $a Kuchař, Jan $7 xx0252933 $u Department of Cardiology, Tabor Hospital, Inc., Czech Republic
- 700 1_
- $a Bělohlávek, Jan, $d 1971- $7 xx0077681 $u Clinical Department of Cardiology and Angiology, 1st Faculty of Medicine, 2nd Medical Department, Charles University, Prague, Czech Republic
- 700 1_
- $a Aschermann, Michael, $d 1944- $7 nlk19990072993 $u Clinical Department of Cardiology and Angiology, 1st Faculty of Medicine, 2nd Medical Department, Charles University, Prague, Czech Republic
- 700 1_
- $a Dytrych, Vladimír $7 xx0080440 $u Clinical Department of Cardiology and Angiology, 1st Faculty of Medicine, 2nd Medical Department, Charles University, Prague, Czech Republic
- 700 1_
- $a Lindner, Jaroslav, $d 1957- $7 mzk2005269705 $u Department of Cardiovascular Surgery, 1st Faculty of Medicine, 2nd Department of Surgery, Charles University, Prague, Czech Republic
- 700 1_
- $a Šimková, Iveta $7 jx20120222045 $u Slovak Medical University and The National Institute for Cardiovascular Diseases, Bratislava, Slovakia
- 700 1_
- $a Linhart, Aleš, $d 1964- $7 mzk2003188958 $u Clinical Department of Cardiology and Angiology, 1st Faculty of Medicine, 2nd Medical Department, Charles University, Prague, Czech Republic
- 773 0_
- $t Bratislavské lekárske listy $x 0006-9248 $g Roč. 121, č. 3 (2020), s. 230-234 $w MED00000845
- 856 41
- $u http://www.elis.sk/download_file.php?product_id=6605&session_id=vqcv5omiqd8n4relp2g02i6ia2 $y plný text volně přístupný
- 910 __
- $a ABA008 $b online $c 1067 $y p $z 0
- 990 __
- $a 20211012144111 $b ABA008
- 991 __
- $a 20240905221111 $b ABA008
- 999 __
- $a ok $b bmc $g 1707780 $s 1145310
- BAS __
- $a 3 $a 4
- BMC __
- $a 2020 $b 121 $c 3 $d 230-234 $i 0006-9248 $m Bratislavské lekárske listy $x MED00000845
- LZP __
- $c NLK194 $d 20240905 $a NLK 2021-43/kv